| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.32 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |